• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

Planmeca Adds the Viso G3 to its CBCT Offerings


The company announces strategic expansion of its CBCT imaging solutions for the North American dental imaging market.

Planmeca Adds the Viso G3 to its CBCT Offerings | Image Credit: © Planmeca

Planmeca Adds the Viso G3 to its CBCT Offerings | Image Credit: © Planmeca

Planmeca has expanded its imaging line for the North American market with the addition of the Planmeca Viso® G3, a multifunctional CBCT device designed to meet all 2D to 3D extraoral imaging needs. The new imaging system delivers usability and visibility for diverse clinics and clinical needs, including endodontics and implantology.

The Planmeca Viso G3 completes the company’s next-generation CBCT units alongside Planmeca Viso G7 and Planmeca Viso G5—all powered by all-in-one Planmeca Romexis dental software.

"We are thrilled to offer this addition to our highly regarded Viso product line," states Glen Kendrick, Planmeca USA president, in this week’s press release. “With all the benefits of Planmeca Viso technology, the Viso G3 allows clinics desiring a 3D with fantastic usability and outstanding image quality to be introduced to the superiority of Planmeca CBCT imaging."

With a Field of View (FOV) ranging from 3 x 3 to 20 x 10 cm, the Planmeca Viso G3 offers high-quality 3D images of the full dentition and the capacity to capture detailed panoramic images and bitewing images for highly detailed diagnosis of interproximal caries.

Advanced Features for Patient Safety
The multifunctional CBCT device features the Planmeca Ultra Low Dose™ protocol, which has been scientifically proven in 9 studies to reduce the effective patient dose without a statistical reduction in image quality, according to the company. Additionally, the proprietary Planmeca CALM® algorithm for motion artifact correction can be applied both before and after acquisition to limit retakes and reduce radiation exposure.

Related Reading: Planmeca Launches Artificial Intelligence Tools for Romexis Platform

The Planmeca Viso G3 includes freely adjustable 3D volume size and anatomical target selection, while the user-friendly patient positioning programs—with a live video view and virtual FOV adjustments—prioritize a patient comfort workflow. Its feature set also is designed to provide a smooth and efficient imaging workflow without compromising safety or patient comfort.

The Planmeca Viso G3 can be upgraded to Planmeca Viso G5 for a larger maximum 3D volume, securing a sustainable solution to grow with an expanding practice. Expanded treatment capability also is available with the addition of the Planmeca ProCeph one-shot cephalostat.

Related Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
2024 Dental Products Report Spring Selection Bracket Reveal Video
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
Contemporary Cosmetic Dentistry – Part II: Arresting Marginal Caries
© 2024 MJH Life Sciences

All rights reserved.